Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study

BACKGROUND: Previous studies have shown amrubicin (AMR) to be an effective second‐line treatment option for small‐cell lung cancer (SCLC). However, the efficacy of AMR in elderly patients with relapsed SCLC has not been sufficiently evaluated. METHODS: The medical records of elderly patients with re...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Thorac Cancer
मुख्य लेखकों: Sone, Hideyuki, Igawa, Satoshi, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Hosotani, Shinji, Ohe, Shuntaro, Ito, Hiroki, Kaizuka, Nobuki, Manaka, Hiroya, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley & Sons Australia, Ltd 2018
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166081/
https://ncbi.nlm.nih.gov/pubmed/30126051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12833
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन